The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode

Stephen T Wrobleski1, Shuqun Lin, T G Murali Dhar

  • 1Department of Immunology Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543-4000, USA. stephen.wrobleski@bms.com

Related Concept Videos